Butterfly Network, INC

Butterfly Network announced record Q2 2026 revenue of $32.6 million, a 39% year-over-year increase, and improved adjusted EBITDA loss, exceeding guidance.

Butterfly Network announced the appointment of Caroll H. Neubauer to its Board of Directors, effective May 18, 2026, strengthening its healthcare industry expertise.

Butterfly Network announces first quarter 2026 financial results, exceeding revenue expectations with 25% year-over-year growth and improved gross margins.

Butterfly Network reported record quarterly revenue of $31.5 million in Q4 2025, marking 41% year-over-year growth and achieving its first quarter of positive operating cash flow.

The New York Stock Exchange has announced the delisting and immediate suspension of trading for Butterfly Network's public warrants due to abnormally low selling prices.

Butterfly Network anticipates at least 17% year-over-year revenue growth for the fourth quarter of 2025, driven by its handheld ultrasound business.

Butterfly Network reports a significant increase in revenue driven by software and services, alongside a reduction in operational losses for the second quarter of 2026.

Butterfly Network reported a 25% increase in total revenue for the first quarter of 2026, driven by strong growth in software and services, while net loss narrowed compared to the prior year period.

Butterfly Network reported a significant increase in net loss and a gross loss for Q3 2025, primarily due to a $17.4 million inventory write-down, despite a capital raise and revenue growth.

Butterfly Network, Inc. announced significant revenue increases and a narrower net loss for the second quarter and first half of 2025, supported by a successful $81 million public share offering.

Butterfly Network's Q1 2025 revenue increased by 20.2% year-over-year, driven by higher product sales and growth in software and services revenue.

Butterfly Network saw a significant increase in product revenue and a decrease in operating expenses in the third quarter of 2024, while still reporting a net loss.

Butterfly Network saw a 19% revenue increase in 2025, driven by new product launches and strategic partnerships, despite a rise in net losses and significant inventory write-downs.

Butterfly Network's 10-K filing reveals a year of revenue growth, strategic shifts, and ongoing efforts to democratize healthcare through innovative ultrasound technology.

Butterfly Network's 10-K filing details its financial results for 2023, strategic shifts, and future growth plans in the medical imaging sector.

Larry Robbins, a Director of Butterfly Network, Inc., sold 1,876,292 shares of common stock on July 31, 2026.

Jonathan M Rothberg, a Director of Butterfly Network, Inc., sold 659,913 shares of common stock on July 22, 2026 for $6.47 per share.

Jonathan M Rothberg, a Director and 10% owner of Butterfly Network, Inc., sold 3,126,453 shares of common stock on July 17, 2026.

Victor Ku, Chief Technology Officer of Butterfly Network, Inc., sold 48,540 shares of common stock on July 20, 2026 for $6.56 per share.

John N. Doherty, EVP, CFO of Butterfly Network, Inc., sold 57,136 shares of common stock on July 20, 2026 for $6.56 per share.

Joseph Devivo, President & CEO and a Director of Butterfly Network, Inc., sold 211,798 shares of common stock on July 20, 2026 for $6.56 per share.

Butterfly Network, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting of stockholders to be held virtually on June 18, 2026.

Butterfly Network, Inc. will hold its 2025 Annual Meeting of Stockholders virtually on June 12, 2025, and provides information on how to vote on key proposals.

Butterfly Network, Inc. will conduct its 2025 annual meeting of stockholders virtually on June 12, 2025, to elect directors, ratify the appointment of Deloitte & Touche LLP, and approve executive compensation.

Butterfly Network, Inc. has filed a definitive proxy statement with the SEC.

Butterfly Network is seeking stockholder approval for several amendments to its corporate charter, including the automatic conversion of Class B common stock and officer exculpation provisions.

Jonathan M. Rothberg and associated entities have filed an amendment to their Schedule 13D, detailing recent stock transactions and beneficial ownership of Butterfly Network, Inc.

Jonathan M. Rothberg and associated entities have updated their Schedule 13D filing concerning Butterfly Network, Inc., detailing recent stock transactions.

Butterfly Network's founder, Dr. Jonathan Rothberg, and related entities have established a Rule 10b5-1 trading plan to sell up to 7.8 million shares of Class A and Class B common stock for estate planning purposes.

Jonathan M. Rothberg, founder of Butterfly Network, Inc., and related entities sold over 2.5 million shares of Class A common stock for approximately $8 million in December 2025 as part of an estate planning 10b5-1 plan.

Jonathan M. Rothberg, founder of Butterfly Network, Inc., sold over 2.46 million Class A common shares in November 2025 for estate planning purposes.

Glenview Capital Management and Larry Robbins have increased their beneficial ownership in Butterfly Network, Inc. through recent open market purchases.

The Vanguard Group has filed an amended Schedule 13G, reporting a 0% beneficial ownership stake in Butterfly Network Inc. following an internal realignment.

Fosun Industrial and Shanghai Fosun Pharmaceutical Group report a combined 4.7% beneficial ownership in Butterfly Network's Class A common stock.

The Vanguard Group has reported a 5% beneficial ownership stake in Butterfly Network Inc., holding over 11 million shares.

BlackRock, Inc. has filed a Schedule 13G, reporting a 6.3% beneficial ownership stake in Butterfly Network, Inc. as of June 30, 2025.

ARK Investment Management LLC has filed an amended Schedule 13G, disclosing a 4.66% beneficial ownership stake in Butterfly Network, Inc. as of September 30, 2024.